Cargando…
Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts
BACKGROUND: Malignant pleural mesothelioma (MPM) is a difficult-to-treat global disease. Pegylated arginase (BCT-100) has recently shown anti-tumor effects in hepatocellular carcinoma, acute myeloid leukemia and melanoma. This study aims to investigate the effects of PEG-BCT-100 in MPM. METHODS: A p...
Autores principales: | Lam, Sze-Kwan, Li, Yuan-Yuan, Xu, Shi, Leung, Leanne Lee, U, Kin-Pong, Zheng, Yan-Fang, Cheng, Paul Ning-Man, Ho, James Chung-Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414232/ https://www.ncbi.nlm.nih.gov/pubmed/28464918 http://dx.doi.org/10.1186/s12931-017-0564-3 |
Ejemplares similares
-
Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models
por: Lam, Sze-Kwan, et al.
Publicado: (2018) -
Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma
por: Lam, Sze-Kwan, et al.
Publicado: (2019) -
Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial–mesenchymal transition
por: Xu, Shi, et al.
Publicado: (2019) -
Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
por: Lam, Sze-Kwan, et al.
Publicado: (2022) -
Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models
por: Lam, Sze-Kwan, et al.
Publicado: (2022)